Mukhtar Nur Farihan, Ng Beng Kwang, Pauzi Suria Hayati Md, Wong Yin Ping, Hamizan Mohammad Rafi'uddin, Lim Pei Shan, Isa Nurismah Md
Department of Obstetrics and Gynaecology, Hospital Tuanku Fauziah, Jalan Tun Abd Razak, 01000 Kangar, Perlis, Malaysia.
Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
Eur J Obstet Gynecol Reprod Biol X. 2023 Jul 20;19:100218. doi: 10.1016/j.eurox.2023.100218. eCollection 2023 Sep.
The uptake of cervical cancer screening is poor, especially in developing countries. Thus, pregnancy represents a good opportunity to have the test done. The aim of this study is to determine the prevalence of abnormal Pap smear among pregnant women during their antenatal check-ups.
A prospective study involving five hundred and ninety-six women was recruited over a 1-year duration from 15th January 2018 until 14th January 2019 in a tertiary referral center, in Malaysia. Pap smears were performed on all consented pregnant women using liquid-based cytology and the results were obtained to evaluate the prevalence of abnormal Pap smear during pregnancy. Maternal risk factors associated with abnormal Pap smear were identified and the outcomes of abnormal Pap smear were followed up.
A total of 670 participants were approached and 596 participants agreed to participate, giving a response rate of 89.0 %. Therefore, 587 participants were available for analysis. There were nine unsatisfactory smears (1.5 %). The prevalence of premalignant lesions reported on p % ap smear was 0.8 %. Three respondents had atypical squamous cells of undetermined significance (ASCUS) (0.5 %) and two respondents had low-grade squamous intraepithelial lesions (LSIL) (0.3 %). Almost one-third (30.3 %) of respondents had an infection and 24 (4.1 %) smears were reported as reactive changes associated with inflammation. Respondents between the age of 20-30 years old had a significant association with an abnormal pre-cancerous smear (p = 0.000) as well as nulliparity (p = 0.0.40). There was no significant association between height, weight, BMI, sexual partner, age of first intercourse, smoking habit, history of sexually transmitted disease and history of abnormal Pap smear.
The prevalence of abnormal pre-cancerous smears during pregnancy is low. However, it is desirable to perform cervical screening as it provides an opportunity to no screening at all.
宫颈癌筛查的接受度很低,尤其是在发展中国家。因此,怀孕是进行该项检查的好时机。本研究的目的是确定孕妇在产前检查期间巴氏涂片异常的患病率。
一项前瞻性研究,于2018年1月15日至2019年1月14日在马来西亚的一家三级转诊中心,历时1年招募了596名女性。对所有同意参与的孕妇进行液基细胞学巴氏涂片检查,并获取结果以评估孕期巴氏涂片异常的患病率。确定与巴氏涂片异常相关的母体风险因素,并对巴氏涂片异常的结果进行随访。
共接触了670名参与者,596名参与者同意参与,应答率为89.0%。因此,有587名参与者可供分析。有9份涂片不满意(1.5%)。巴氏涂片报告的癌前病变患病率为0.8%。3名应答者有意义不明确的非典型鳞状细胞(ASCUS)(0.5%),2名应答者有低度鳞状上皮内病变(LSIL)(0.3%)。近三分之一(30.3%)的应答者有感染,24份(4.1%)涂片报告为与炎症相关的反应性改变。年龄在20至30岁之间的应答者与癌前涂片异常有显著关联(p = 0.000),以及与未生育也有显著关联(p = 0.040)。身高、体重、BMI、性伴侣、首次性交年龄、吸烟习惯、性传播疾病史和巴氏涂片异常史之间无显著关联。
孕期癌前涂片异常的患病率较低。然而,进行宫颈筛查是可取的,因为它提供了一个原本完全没有筛查的机会。